Vanson Plans Second Clinical on LipoSan Ultra

Vanson Plans Second Clinical on LipoSan Ultra

REDMOND, Wash.--Vanson HaloSource will begin aclinical study on the efficacy of LipoSan Ultra for weight loss later this year.The double blind, placebo-controlled human trial will begin the second quarterof 2003, with results to be published by the end of the year. It is beingconducted by an independent research organization.

A study published in the Journal of the AmericanNutraceutical Association in 2001 showed patients taking LipoSan Ultra hadsignificant weight loss compared to those taking placebo. "Our consumersand industry professionals already trust LipoSan Ultra as a scientificallyproven, simple and safe way to control weight when used with a proper diet andexercise program," said Everett Nichols, vice president of research anddevelopment with Vanson.

For more information, visit www.vanson.comor Wilke Resources' Booth #1318-1320 at SupplySide East.